Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hans Olav Beisland"'
Autor:
Gudmund Waaler, Jahn M. Nesland, Einar Servoll, Hans Olav Beisland, Tormod Lund, Thorstein Sæter, Ljiljana Vlatkovic, Karol Axcrona
Publikováno v:
BJU International. 109:1489-1494
UNLABELLED Study Type - Prognosis (case series) Level of Evidence 4 What's known on the subject? and What does the study add? It is known that a tertiary Gleason grade pattern 4 or 5 found in RP specimens has a negative impact on recurrence rate rega
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 38:299-305
To gain knowledge about when, where and how metastases after presumed radical treatment for renal cell carcinoma (RCC) are detected, and to use this information to establish a follow-up programme for radically treated RCC. Further aims were to establ
Publikováno v:
European Urology. 37:58-64
To gain information about the indications for and complications of conventional nephrectomy, also to create standards for future evaluation of nephrectomies performed by minimal invasive techniques.We present a historical 20 years' series of 646 cons
Autor:
Gudmund Waaler, Einar Servoll, Ljiljana Vlatkovic, Thorstein Sæter, Jahn M. Nesland, Hans Olav Beisland
Publikováno v:
Scandinavian journal of urology and nephrology. 44(4)
The presence of a tertiary Gleason grade (TGG) pattern 4 or 5 in radical prostatectomy (RP) specimens has been reported with adverse pathology and a higher biochemical relapse rate after RP. This study investigated the impact of a TGG pattern 4 or 5
Autor:
Oncko Van Vierssen Trip, Robert G. Hahn, Teuvo L.J. Tammela, Betsy Morrill, A. Duggan, Tim Fagerström, Hans Olav Beisland
Publikováno v:
BJU international. 99(3)
The relationship between 5α-reductase inhibitors and blood loss from the prostate has been well described and investigated previously. In a well-conducted study, authors from Sweden show that dutasteride, despite significantly lowering the tissue di
Autor:
Hans Olav Beisland, Christian Beisland
Publikováno v:
Europe PubMed Central
The many improvements in diagnostic and therapeutic tools over the last half-century have changed the prospects for patients with renal cell carcinoma (RCC). Higher survival rates and less morbidity have been achieved. The disease is, however, still
Publikováno v:
Scandinavian journal of urology and nephrology. 36(6)
To look for an increase in the incidental detection of renal cell carcinoma (RCC) over the last two decades and to see if different patterns of healthcare use for men and women have implications for tumour detection and survival.We present an histori
Autor:
Hans Olav Beisland, Per Seland
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 20:209-212
122 patients with urinary bladder cancer of stage T-1 and T-2 were randomized for Neodymium-YAG laser irradiation (n = 62) or TUR (n = 60). Follow-up was carried out every 3 months for 2 years. Recurrence of tumor in treated area was seen in 3 patien
Autor:
Erling Fossberg, Hans Olav Beisland
Publikováno v:
Journal of the American Geriatrics Society. 33:29-32
Twenty-five geriatric patients with severe motor urge incontinence were treated with terodiline and meladrazine separately and in combination. Because of poor general state of health and serious concomitant diseases the frequency of dropouts was high
Autor:
Frode Lærum, Hans Olav Beisland
Publikováno v:
European Urology. 12:39-42
Transrectal ultrasonography was used to evaluate 54 patients with localized prostatic carcinoma treated with neodymium-YAG laser irradiation. Both pre- and postirradiation scans were obtained in 30 patients, while additional 24 cases were examined af